Dr June Raine pays tribute to the successful switches of the past 25 years and the contribution that many have made to public health. Flagging up the key public health issues which could be triggers for the next wave of switches.
Biography:
Dr June Raine trained in general medicine in Oxford after completing a Masters degree by research in Pharmacology. Her interest in drug safety led to a career in medicines regulation which has spanned a number of roles in assessment, management and strategic development within the UK national authority. Appointed in 1999 to head Pharmacovigilance in the Medicines Control Agency (now Medicines and Healthcare products Regulatory Agency), she was elected in 2005 to chair the CHMP’s Pharmacovigilance Working Party. She is also a member of the WHO Advisory Committee on Safety of Medicinal Products. Her special interests are in monitoring the outcomes of regulatory action, risk communication and patient involvement in the regulatory process.
Moving forward with reclassification – the regulators perspective (7.32)
3) Dr June Raine (MHRA)